Adverse Drug Events in U.S. Adult Ambulatory Medical Care

Benzer Materyaller

• Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database
  Yazar:: Wen-Hui Liu, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-11-01)
• Signal and noise: applying a laboratory trigger tool to identify adverse drug events among primary care patients
  Yazar:: Brenner, Stacey, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study
  Yazar:: Eckstrand Julie, ve diğerleri
  Baskı/Yayın Bilgisi: (2010-02-01)
• Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study
  Yazar:: Long, Andrea L, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Comparison of Brand versus Generic Antiepileptic Drug Adverse Event Reporting Rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
  Yazar:: Rahman, Md. Motiur, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)